The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Host cyclooxygenase-2 modulates carcinoma growth
Open accessAbstract
Cyclooxygenase-2 (COX-2; Ptgs2) acts as a tumor promoter in rodent models for colorectal cancer, but its precise role in carcinogenesis remains unclear. We evaluated the contribution of host-derived COX-1 and COX-2 in tumor growth using both genetic and pharmacological approaches. Lewis lung carcinoma (LLC) cells grow rapidly as solid tumors when implanted in C57BL/6 mice. We found that tumor growth was markedly attenuated in COX-2(-/-), but not COX-1(-/-) or wild-type mice. Treatment of wild-type C57BL/6 mice bearing LLC tumors with a selective COX-2 inhibitor also reduced tumor growth. A decrease in vascular density was observed in tumors grown in COX-2(-/-) mice when compared with those in wild-type mice. Because COX-2 is expressed in stromal fibroblasts of human and rodent colorectal carcinomas, we evaluated COX-2(-/-) mouse fibroblasts and found a 94% reduction in their ability to produce the proangiogenic factor, VEGF. Additionally, treatment of wild-type mouse fibroblasts with a selective COX-2 inhibitor reduced VEGF production by 92%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272 · cited 1×
“It has been demonstrated using in vitro assays that COX-2 can influence angiogenesis (23, 33, 34) and that treatment with selective COX-2 inhibitors blocks angiogenesis (23, 34, 35).”
Self-citationVessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Self-citationExpression of cyclooxygenase-1 and -2 in human colorectal cancer.
Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., & Hla, T. (1995) · PubMed · Cited by 1,126
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 969
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Self-citationHanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., & Rigas, B. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00181-5 · Cited by 608
Landscaping the Cancer Terrain
Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.280.5366.1036 · Cited by 516
The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., & Prescott, S. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4816 · Cited by 449
DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., & Bishop, P. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116998 · Cited by 373
Self-citationChakraborty, I., Das, S. K., Wang, J., & Dey, S. K. (1996) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0160107 · Cited by 338
Self-citationWang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22044 · Cited by 337
Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N. M., & Han, R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1939 · Cited by 328
Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.657 · Cited by 316
Self-citationAchiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., & Takahashi, T. (1999) · PubMed · Cited by 310
Elevated cyclooxygenase-2 levels in Min mouse adenomas
Williams, C., Luongo, C., Radhika, A., Zhang, T., Lamps, L., Nanney, L., Beauchamp, R., & DuBois, R. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70083-5 · Cited by 303
Self-citationThromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel, T. O., Liu, H., Morrow, J. D., et al. (1999) · PubMed · Cited by 295
Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas
Chapple, K. S., Cartwright, E. J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A. C. J., Guillou, P. J., Markham, A. F., Coletta, P. L., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64759-1 · Cited by 218
Cheng, T., Cao, W., Wen, R., Steinberg, R. H., & LaVail, M. M. (1998) · PubMed · Cited by 203
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
DuBois, R. N., Shao, J., Tsujii, M., Sheng, H., & Beauchamp, R. D. (1996) · PubMed · Cited by 183
Self-citationCyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL–10−/− mice
Shattuck-Brandt, R. L., Varilek, G. W., Radhika, A., Yang, F., Washington, M. K., & DuBois, R. N. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70216-2 · Cited by 179
Self-citationChakraborty, I., Das, S. K., & Dey, S. K. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470339 · Cited by 163
Self-citationReduced COX-2 protein in colorectal cancer with defective mismatch repair.
Karnes, W. E., Shattuck-Brandt, R. L., Burgart, L. J., DuBois, R. N., Tester, D. J., Cunningham, J. M., Kim, C. Y., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 138
Self-citationHöper, M. M., Voelkel, N. F., Bates, T. O., Allard, J. D., Horan, M. P., Shepherd, D., & Tuder, R. M. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.6.2888 · Cited by 137
Nishimura, G., Yanoma, S., Mizuno, H., Kawakami, K., & Tsukuda, M. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00690.x · Cited by 101
The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat
Yamada, M., Kawai, M., Kawai, Y., & Mashima, Y. (1999) · Current Eye Research · doi:10.1076/ceyr.19.4.300.5301 · Cited by 83
Shao, J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.185 · Cited by 80
Cited by
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
“In both benign and malignant mouse intestinal tumours, stromal expression of cyclooxygenase-2 (COX2) results in elevated prostaglandin E 2 (PGE 2 ) levels, which in turn stimulate expression of the cell-surface prostaglandin receptor EP 2 , followed by induction of VEGF and angiogenesi”
BackgroundBissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Metadata
- Authors
- Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-06-01
- Volume
- 105
- Issue
- 11
- Pages
- 1589-1594
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2165663767
- Cited by
- 673
- References
- 34
- FWCI
- 41.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.